Human esophageal cancer is distinguished from adjacent esophageal tissue by tissue cysteine concentrations
- PMID: 12498295
- DOI: 10.1023/a:1021009322843
Human esophageal cancer is distinguished from adjacent esophageal tissue by tissue cysteine concentrations
Abstract
Recent studies have suggested that cysteine, in addition to glutathione, may play a role in the genesis, pathobiology, and treatment response of rodent and human cancers. We examined the relative concentrations of cysteine and glutathione in human esophageal cancer and adjacent, minimally involved esophageal tissue. Small biopsies from tumors and adjacent esophageal tissues were placed into cold acid to allow extraction of low-molecular-mass compounds and simultaneous precipitation of macromolecules. Supernatants were analyzed by high-performance liquid chromatography with electrochemical detection for thiol content. While there was no statistically significant difference between the glutathione content of tumor versus adjacent tissue (2.2 mM vs 2.1 mM, respectively), tumor tissue had significantly higher levels of cysteine than adjacent tissue (0.21 mM vs 0.13 mM, respectively). In conclusion, cysteine content distinguishes tumor from adjacent more normal tissue.
Similar articles
-
Cysteine concentrations in rodent tumors: unexpectedly high values may cause therapy resistance.Int J Cancer. 1996 Sep 4;67(5):661-7. doi: 10.1002/(SICI)1097-0215(19960904)67:5<661::AID-IJC12>3.0.CO;2-8. Int J Cancer. 1996. PMID: 8782655
-
Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.Hum Pathol. 2001 Nov;32(11):1157-65. doi: 10.1053/hupa.2001.28951. Hum Pathol. 2001. PMID: 11727253
-
Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence.Ann Surg Oncol. 2007 Nov;14(11):3232-42. doi: 10.1245/s10434-007-9528-z. Epub 2007 Aug 8. Ann Surg Oncol. 2007. PMID: 17682823
-
Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.World J Surg Oncol. 2015 Apr 8;13:141. doi: 10.1186/s12957-015-0557-y. World J Surg Oncol. 2015. PMID: 25886188 Free PMC article.
-
Esophageal zinc content in human squamous esophageal cancer.J Am Coll Nutr. 1987 Feb;6(1):41-6. doi: 10.1080/07315724.1987.10720164. J Am Coll Nutr. 1987. PMID: 3584728
Cited by
-
Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma.Front Oncol. 2022 Feb 7;12:829350. doi: 10.3389/fonc.2022.829350. eCollection 2022. Front Oncol. 2022. PMID: 35198450 Free PMC article.
-
Dual-locked fluorescent probes for precise diagnosis and targeted treatment of tumors.Heliyon. 2024 Sep 19;10(18):e38174. doi: 10.1016/j.heliyon.2024.e38174. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39381214 Free PMC article. Review.
-
Tissue Metabonomic Phenotyping for Diagnosis and Prognosis of Human Colorectal Cancer.Sci Rep. 2016 Feb 15;6:20790. doi: 10.1038/srep20790. Sci Rep. 2016. PMID: 26876567 Free PMC article.
-
Exploring metabolic reprogramming in esophageal cancer: the role of key enzymes in glucose, amino acid, and nucleotide pathways and targeted therapies.Cancer Gene Ther. 2025 Feb;32(2):165-183. doi: 10.1038/s41417-024-00858-5. Epub 2025 Jan 10. Cancer Gene Ther. 2025. PMID: 39794467 Review.
-
Leveraging the Aminothiol-Specific Phosphorogenic Response of Iridium(III) Thioester Complexes for the Development of Intracellular Sensors and Cancer Phototherapeutics.JACS Au. 2025 Jun 10;5(6):2825-2836. doi: 10.1021/jacsau.5c00413. eCollection 2025 Jun 23. JACS Au. 2025. PMID: 40575299 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical